Slough, United Kingdom

Christopher James Lock



Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 52(Granted Patents)


Location History:

  • Slough, GB (2013 - 2014)
  • Saffron Walden, GB (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Christopher James Lock

Introduction

Christopher James Lock is an esteemed inventor based in Slough, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents under his belt, Lock has dedicated his career to developing innovative solutions for complex medical conditions. His work has greatly impacted the landscape of drug discovery and therapeutic advancements.

Latest Patents

Lock’s latest inventions include two significant patents. The first, titled "Amido Thiadiazole Derivatives as NADPH Oxidase Inhibitors," relates to amino thiazole derivatives of Formula (I). This invention is crucial in developing pharmaceutical compositions aimed at treating or preventing disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

The second patent, "Fused Pyridine Derivatives as Kinase Inhibitors," focuses on a series of heteroaryl-substituted fused pyridine derivatives, particularly thieno[3,2-6]pyridine derivatives. These compounds act as selective inhibitors of PO kinase enzymes, providing substantial benefits in treating a variety of medical conditions, including inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, and ophthalmic issues.

Career Highlights

Throughout his career, Christopher James Lock has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with UCB Pharma, S.A. and Genkyotex Suisse SA, where he contributed to significant research and development projects. His work has been integral in driving forward innovative therapeutic options that address pressing health challenges.

Collaborations

Lock's collaborative efforts include working alongside notable colleagues such as Andrew James Ratcliffe and Andrew Sharpe. These partnerships have not only enriched his research endeavors but have also fostered an environment of innovation and creativity in the field of medicinal chemistry.

Conclusion

Christopher James Lock is a remarkable inventor whose innovative patents continue to pave the way for advancements in medicine. His dedication to addressing complex health issues through scientific research exemplifies the impact one individual can have in the world of pharmaceuticals. As his career progresses, it will be exciting to follow his future contributions to the field and the ongoing evolution of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…